Differential diagnosis of suspected multiple sclerosis: an updated consensus approach.
Solomon AJ, Arrambide G, Brownlee WJ, Flanagan EP, Amato MP, Amezcua L, Banwell BL, Barkhof F, Corboy JR, Correale J, Fujihara K, Graves J, Harnegie MP, Hemmer B, Lechner-Scott J, Marrie RA, Newsome SD, Rocca MA, Royal W 3rd, Waubant EL, Yamout B, Cohen JA.
Lancet Neurol. 2023 Aug;22(8):750-768. doi: 10.1016/S1474-4422(23)00148-5.
THINKING AND DEPRESSION. I. IDIOSYNCRATIC CONTENT AND COGNITIVE DISTORTIONS.
BECK AT.
Arch Gen Psychiatry. 1963 Oct;9:324-33. doi: 10.1001/archpsyc.1963.01720160014002.
The biopsychosocial model: Its use and abuse.
Roberts A.
Med Health Care Philos. 2023 Sep;26(3):367-384. doi: 10.1007/s11019-023-10150-2. Epub 2023 Apr 17.
Formal Thought Disorder and language impairment in schizophrenia.
Radanovic M, Sousa RT, Valiengo L, Gattaz WF, Forlenza OV.
Arq Neuropsiquiatr. 2013 Jan;71(1):55-60. doi: 10.1590/s0004-282x2012005000015. Epub 2012 Dec 18.
The thought disorder questionnaire.
Waring EM, Neufeld RW, Schaefer B.
Can J Psychiatry. 2003 Feb;48(1):45-51. doi: 10.1177/070674370304800109.
Thought disorder in mid-childhood as a predictor of adulthood diagnostic outcome: findings from the New York High-Risk Project.
Gooding DC, Ott SL, Roberts SA, Erlenmeyer-Kimling L.
Psychol Med. 2013 May;43(5):1003-12. doi: 10.1017/S0033291712001791. Epub 2012 Aug 30.
Dream content and intrusive thoughts in Obsessive-Compulsive Disorder.
Cavallotti S, Casetta C, Fanti V, Gambini O, Ostinelli EG, Ranieri R, Vanelli I, D'Agostino A.
Psychiatry Res. 2016 Oct 30;244:410-4. doi: 10.1016/j.psychres.2016.08.008. Epub 2016 Aug 4.
Assessing dimensions of thought disorder with large language models: The tradeoff of accuracy and consistency.
Pugh SL, Chandler C, Cohen AS, Diaz-Asper C, Elvevåg B, Foltz PW.
Psychiatry Res. 2024 Nov;341:116119. doi: 10.1016/j.psychres.2024.116119. Epub 2024 Aug 3.
Predictive value of thought disorder in new-onset psychosis.
Wilcox J, Winokur G, Tsuang M.
Compr Psychiatry. 2012 Aug;53(6):674-8. doi: 10.1016/j.comppsych.2011.12.002. Epub 2012 Feb 17.
Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy.
Chen ST, Semenov YR, Alloo A, Bach DQ, Betof Warner A, Bougrine A, Burton L, Cappelli LC, Castells M, Cohen J, Dewan AK, Fadden R, Guggina L, Hegde A, Huang V, Johnson DB, Kaffenberger B, Kroshinsky D, Kwatra S, Kwong B, Lacouture ME, Larocca C, Leventhal J, Markova A, McDunn J, Mooradian MJ, Naidoo J, Choi J, Nambudiri V, Nelson CA, Patel AB, Pimkina J, Rine J, Rubin KM, Sauder M, Shaigany S, Shariff A, Sullivan RJ, Zubiri L, Reynolds KL, LeBoeuf NR.
J Immunother Cancer. 2024 Apr 10;12(4):e007675. doi: 10.1136/jitc-2023-007675.
